News
Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...
Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business
Charles River Labs said first-quarter earnings rose and it's raising its full-year outlook. The company also entered into an agreement with Elliott Investment Management and said it would conduct a ...
James C. Foster, Chair, President, and CEO of Charles River Laboratories, emphasized the company’s proactive approach to navigating market conditions and its commitment to growth. Foster expressed ...
Charles River Laboratories said on Wednesday it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its board.
BEVERLY HILLS (Reuters) -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and ...
(Reuters) - Charles River Laboratories said on Wednesday it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its board. Charles River's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results